系统综述与荟萃分析:MRI特征鉴别自身免疫性胰腺炎与胰腺导管腺癌
该系统综述与荟萃分析纳入12项研究,将92个重叠描述词归纳为16个MRI特征,用双变量随机效应模型计算各特征鉴别自身免疫性胰腺炎(AIP)与胰腺导管腺癌(PDAC)的诊断比值比(DOR)。AIP相关特征中DOR最高者为弥漫性肿大(75)、包膜样边缘(52)、主胰管多发狭窄(47)和均匀延迟强化(46);PDAC相关特征中DOR最高者为靶型强化(41)和离散性肿块(35)。
要点
- 弥漫性肿大(DOR 75)、包膜样边缘(52)、主胰管多发狭窄(47)、均匀延迟强化(46)支持AIP。
- 靶型强化(DOR 41)与离散性肿块(35)支持PDAC。
- 主胰管上游扩张、胰周脂肪浸润、上游胰腺实质萎缩、血管受累支持PDAC。
核心结论
- 本研究识别出16个有助于鉴别AIP与PDAC的MRI特征,其中弥漫性肿大、包膜样边缘、主胰管多发狭窄和均匀延迟强化支持AIP的DOR最高,离散性肿块和靶型强化支持PDAC。
研究设计与样本
- 系统文献综述与荟萃分析,检索PubMed、EMBASE和Cochrane Library,纳入2006年1月至2021年7月发表的原创文章,共纳入12项研究;将92个重叠描述词归纳为16个MRI特征;采用双变量随机效应模型计算各特征的诊断比值比(DOR)及95%置信区间(CI)。
关键影像表现/征象
- 支持AIP的MRI特征包括弥漫性肿大(DOR 75;95% CI 9-594)、包膜样边缘(DOR 52;95% CI 20-131)、主胰管多发狭窄(DOR 47;95% CI 17-129)、均匀延迟强化(DOR 46;95% CI 21-104)、低表观扩散系数值(DOR 30)、斑点状强化(DOR 30)、胰腺多发肿块(DOR 29)、主胰管逐渐变细狭窄(DOR 15)、穿管征(DOR 14)和延迟强化(DOR 13)。
- 支持PDAC的MRI特征包括靶型强化(DOR 41;95% CI 11-158)、离散性肿块(DOR 35;95% CI 15-80)、主胰管上游扩张(DOR 13)、胰周脂肪浸润(DOR 10)、上游胰腺实质萎缩(DOR 5)和血管受累(DOR 3)。
诊断标准与关键数值
- 支持AIP的特征及其DOR(95% CI):弥漫性肿大75(9-594)、包膜样边缘52(20-131)、主胰管多发狭窄47(17-129)、均匀延迟强化46(21-104)、低表观扩散系数值30、斑点状强化30、胰腺多发肿块29、主胰管逐渐变细狭窄15、穿管征14、延迟强化13。
- 支持PDAC的特征及其DOR(95% CI):靶型强化41(11-158)、离散性肿块35(15-80)、主胰管上游扩张13、胰周脂肪浸润10、上游胰腺实质萎缩5、血管受累3。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To identify reliable MRI features for differentiating autoimmune pancreatitis (AIP) from pancreatic ductal adenocarcinoma (PDAC) and to summarize their diagnostic accuracy.
METHODS: We conducted a systematic literature review and meta-analysis using PubMed, EMBASE, and the Cochrane Library to identify original articles published between January 2006 and July 2021. The pooled diagnostic accuracy, including the diagnostic odds ratios (DORs) with 95% confidence intervals (CIs) of the identified features, was calculated using a bivariate random effects model.
RESULTS: Twelve studies were included, and 92 overlapping descriptors were subsumed under 16 MRI features. Ten features favoring AIP were diffuse enlargement (DOR, 75; 95% CI, 9-594), capsule-like rim (DOR, 52; 95% CI, 20-131), multiple main pancreatic duct (MPD) strictures (DOR, 47; 95% CI, 17-129), homogeneous delayed enhancement (DOR, 46; 95% CI, 21-104), low apparent diffusion coefficient value (DOR, 30), speckled enhancement (DOR, 30), multiple pancreatic masses (DOR, 29), tapered narrowing of MPD (DOR, 15), penetrating duct sign (DOR, 14), and delayed enhancement (DOR, 13). Six features favoring PDAC were target type enhancement (DOR, 41; 95% CI, 11-158), discrete pancreatic mass (DOR, 35; 95% CI, 15-80), upstream MPD dilatation (DOR, 13), peripancreatic fat infiltration (DOR, 10), upstream parenchymal atrophy (DOR, 5), and vascular involvement (DOR, 3).
CONCLUSION: This study identified 16 informative MRI features to differentiate AIP from PDAC. Among them, diffuse enlargement, capsule-like rim, multiple MPD strictures, and homogeneous delayed enhancement favored AIP with the highest DORs, whereas discrete mass and target type enhancement favored PDAC.
KEY POINTS: • The MRI features with the highest pooled diagnostic odds ratios (DORs) for autoimmune pancreatitis were diffuse enlargement of the pancreas (75), capsule-like rim (52), multiple strictures of the main pancreatic duct (47), and homogeneous delayed enhancement (46). • The MRI features with the highest pooled DORs for pancreatic ductal adenocarcinoma were target type enhancement (41) and discrete pancreatic mass (35).
引用
- Yoon SB, Jeon TY, Moon SH, et al. Systematic review and meta-analysis of MRI features for differentiating autoimmune pancreatitis from pancreatic adenocarcinoma. Eur Radiol. 2022. PMID: 35486167. doi:10.1007/s00330-022-08816-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。